Business NewsMarketWire • Vernalis Announces Successful Completion of CCP-08 Pivotal Multiple-Dose Comparative Bioavailability Study

Vernalis Announces Successful Completion of CCP-08 Pivotal Multiple-Dose Comparative Bioavailability Study

Vernalis Announces Successful Completion of CCP-08 Pivotal Multiple-Dose Comparative Bioavailability Study

WINNERSH, UNITED KINGDOM--(Marketwired - Jul 8, 2016) - Vernalis PLC (LSE: VER); (OTC PINK: VNLPY)

View More : http://www.marketwired.com/mw/release.do?id=2140785&sourceType=3
Releted News by marketwire
topcreditcardprocessors.com Unveils Credit Card Processing Specialists as the Second Top Credit Card Processing Service for the Month of July 2016
topcreditcardprocessors.com Announces Ratings of 10 Top Chargeback Prevention Services for July 2016
Vernalis Announces Successful Completion of CCP-08 Pivotal Multiple-Dose Comparative Bioavailability Study